Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Chiesi and Bespak partner to advance Carbon Minimal Inhaler production

Summary by European Pharmaceutical Manufacturer
Chiesi and and Bespak have announced an expansion of their partnership, increasing pMDI manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

European Pharmaceutical ManufacturerEuropean Pharmaceutical Manufacturer

Chiesi and Bespak partner to advance Carbon Minimal Inhaler production

Chiesi and and Bespak have announced an expansion of their partnership, increasing pMDI manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

European Pharmaceutical Manufacturer broke the news in on Friday, March 13, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Holmes Chapel icon

Holmes Chapel

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal